Helping Healthcare & Life Sciences Leaders Navigate Risk, Ensure Compliance, and Protect Patient Trust

Pharmaceutical and life-sciences companies operate under intense regulatory scrutiny, managing vast networks of healthcare professionals, suppliers, distributors, and partners across multiple jurisdictions. From anti-bribery compliance to clinical integrity and third-party risk, challenges are complex—and the consequences of missteps severe.

Mintz Group partners with compliance, legal, procurement, and corporate-integrity teams to deliver tailored investigative intelligence that safeguards reputations, mitigates exposure under global anti-bribery and corruption laws, and supports ethical business practices. Whether vetting distributors, reviewing clinical investigators, or responding to whistleblower allegations, we provide discreet, defensible, and decision-ready insights across markets.

What We Help Clients Solve

Comprehensive Third-Party Due Diligence

We perform tiered screening and enhanced investigations on suppliers, distributors, agents, and vendors, identifying beneficial ownership, political exposure, and sanctions risks while integrating with onboarding workflows.

Healthcare Professional & Key Opinion Leader Vetting

We verify credentials, affiliations, and disciplinary histories, review public disclosures and conflicts of interest, and monitor global enforcement actions to ensure compliance with transparency regulations.

Investigative Support & Integrity Reviews

We conduct discreet inquiries into whistleblower allegations, conflicts, or suspected misconduct, and perform deep-dive integrity checks before licensing, distribution, or M&A decisions—even in opaque markets.

Regulatory & Market-Entry Risk Analysis

We assess exposure to anti-bribery laws, sanctions, and local compliance frameworks, providing actionable intelligence for expansion strategies and high-stakes transactions in sensitive jurisdictions.